The satisfaction rate among Extra Super Avana users can vary based on individual factors such as the severity of erectile dysfunction (ED), premature ejaculation (PE), overall health, and adherence to treatment. However, data from studies on its components—avanafil and dapoxetine—suggest the following general trends:

Efficacy of Avanafil: Clinical studies have shown that avanafil, which is a component of Extra Super Avana, has a high success rate in treating ED. Many users report satisfactory results, with a significant number achieving improved erectile function.

Efficacy of Dapoxetine: Dapoxetine, the other active ingredient, is effective in treating premature ejaculation. It helps in delaying ejaculation and improving control, leading to increased satisfaction for many users.

Combined Effect: The combination of avanafil and dapoxetine aims to address both ED and PE simultaneously. Users who have both conditions often report high levels of satisfaction due to the dual action of the medication.

Patient Satisfaction: In studies, many patients report positive outcomes with combination therapies like Extra Super Avana. Satisfaction rates can be high, often exceeding 60-70%, depending on the study and the specific patient population.

Individual experiences can vary, so it's important for users to discuss their specific results with their healthcare provider. If users have concerns or do not achieve the desired results, adjustments to the dosage or alternative treatments may be considered.